Dicerna Pharmaceuticals, Inc.
THERAPEUTIC INHIBITION OF LACTATE DEHYDROGENASE AND AGENTS THEREFOR
Last updated:
Abstract:
This invention relates to compounds, compositions, and methods useful for reducing lactact dehydrogenase target RNA and protein levels via use of ds RNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.
Status:
Application
Type:
Utility
Filling date:
15 Mar 2019
Issue date:
24 Oct 2019